In the writings here, I have argued that we are often denied vital knowledge, treatments, and care to protect the interests of the medical-industrial complex. In my eyes, the story of Ultraviolet Blood Irradiation provides one of the clearest examples of this corruption.
In contrast, a 20-year study of 29,518 Swedish women found that those who avoided sunlight were 130% more likely to die than those who received regular sunlight and were also more likely to develop significant medical conditions, including cancer.
Likewise, in the first part of this series, I highlighted the pivotal role of natural light in: How to Invest in Gold ... Best Price: $22.75 Buy New $18.16 (as of 03:43 UTC - Details)
- Cancer and Infections.
- Circulation.
- Behavioral disorders.
- Animal health, fertility, and agricultural productivity.
- Regulating growth cycles and the circadian rhythm.
Unfortunately, natural light is rarely found indoors (e.g., standard glass blocks it), and since the eyes are the primary site of light absorption, those who wear glasses or contacts (like those with darker skin) are particularly vulnerable to light deficiency illnesses. In turn, remarkable results have been obtained from putting light directly into the body.
The History of Ultraviolet Blood Irradiation
One of the oldest “proven” therapies in medicine was having people bathe in sunlight. For example, it was one of the few things that actually had success in treating the 1918 influenza, and (prior to antibiotics), tuberculosis.
Before long, the medical field realized sunlight’s ultraviolet component was a sterilizing agent (along with UVC—a type of UV light that is blocked by the ozone layer), and a variety of sanitizing UV devices were developed (e.g., most recently, exposing air to UV light was demonstrated to be an effective way to prevent COVID-19 transmission).
In 1927, Emmett Knott, not a doctor, experimented with sterilizing blood using UV light to combat septicemia. Initially unsuccessful, his approach involved irradiating the entire blood volume of infected dogs. A fortunate accident in 1928, where Knott under-dosed a dog, led to a dramatic recovery, demonstrating that a small amount of blood needed irradiation for the treatment to be effective.
Knott’s first human trial in 1933 saved a woman dying from septicemia. He then refined his method and, starting in 1937, successfully promoted UVBI across the U.S. By the 1940s, doctors found UVBI highly effective against challenging conditions like sepsis, pneumonia, nephritis, asthma, polio, botulism, rheumatic fever, and viral hepatitis.
This was miraculous and by the early 1950s, UVBI was used in around 50 American hospitals. Doctors in 50 papers covering over 3,000 patients reported consistent but unbelievable results, even in severe infection cases where antibiotics failed.
The literature of the time documented many notable cases such as a man with multiple severe conditions, including brain and lung clots, pneumonia, and paralysis. UVBI led to his near-instant recovery, and he eventually regained his health completely. Likewise, prominent media outlets like The New York Times, Time Magazine, and The American Weekly featured articles on its success.
“I think personally that [Knott’s discovery] is one of the greatest contributions to medicine ever made by a citizen of the United States.” — George Miley MD (1940)
Market Monopolization
At this point, the American Medical Association (AMA) got involved, and as they had done to many other promising therapies, attempted to extort Knott by offering to prove UVBI worked in return for the rights to it. Knott refused and the AMA conducted a biased study that was designed to fail. Despite its data saying otherwise, it concluded:
We have concluded that none of our patients derived benefit from the irradiation of blood with the Knott hemo-irradiator
Hospitals, relying on the “authoritative” study’s misleading conclusion, abandoned UVBI in favor of antibiotics. Fortunately, UVBI found new life overseas (e.g., in Russia and Germany) as it offered a much more economical way to practice medicine.
Note: the suppression of UVBI mirrors the fate of other lifesaving therapies which were blacklisted through rigged clinical trials like IV vitamin C for sepsis, ivermectin and hydroxychloroquine for COVID-19, and numerous promising cancer treatments (all of which I discussed further here).
Physiologic Effects of UVBI
Once ultraviolet light contacts the bloodstream, the following rapidly occurs:
•The body relaxes, the skin pinkens, circulation greatly improves, cyanosis disappears and pain reduces or disappears.
•All abnormal vital signs normalize.
•”Toxic” conditions (e.g., botulism or sepsis) resolve.
•Autonomic function normalizes (e.g., peristalsis resumes).
•Venous oxygenation (if depleted) increases by 25-58%.
•White blood cell counts normalize (as does a variety of other abnormal bloodwork).
Note: this normalization helps explain why UVBI is highly effective against both infections and autoimmune conditions.
These effects, in turn, help to explain how UV can cause patients on the brink of death to stabilize rapidly, something almost never seen in critical care medicine (and which I’ve argued is a property of UVBI improving the systemic zeta potential—something we believe is critical for health). 10-Minute Strength Tra... Best Price: $12.19 Buy New $9.29 (as of 03:52 UTC - Details)
Additionally, delayed effects (e.g., the body mounting an immune response against an infection or a general sense of wellness) are often seen days to weeks after a UVBI treatment.
The rapid systemic response to irradiating a small portion of the blood in turn suggests that blood is able to conduct light. This is supported by numerous observations such as the profound health effects of insufficient sunlight reaching the eyes. Mechanistically this conduction is possible due to the energy transferring properties of hemoglobin.
How is Blood Irradiated?
Classically, UVBI involves removing a small amount of blood (40-60ml), diluting it, and then infusing it back into the body while passing it through UV light.
Note: one argument for blood conducting light is that externally illuminating blood connected to the circulation will create a systemic shift long before the small amount of irradiated blood can reach the IV and enter the circulation.
In the early 1980s, German and Russian researchers realized light could also be put into the body through a laser either applied externally through the skin, or internally through an illuminated catheter. Laser blood irradiation (LBI) has similar effects to extracorporeal UVBI, with LBI having a faster onset but typically requiring more treatments, while UVBI has stronger bactericidal, anti-inflammatory, and circulatory effects.